Streetbeat News

Partnerships

KARS

KGRN

NIO

NIO Inc. (NYSE:NIO) shares are trading nearly flat today, having lost over 71% in the past year. NIO's charging network has been integrated with Hellobike's services, offering discounts to users. NIO is also constructing two new vehicle assembly plants. Investors can gain exposure to NIO via KraneShares MSCI China Clean Technology Index ETF (NYSE:KGRN) and KraneShares Electric Vehicles and Future Mobility Index ETF (NYSE:KARS).

Portfolio Pulse from Nabaparna Bhattacharya

August 09, 2024 | 2:30 pm

LFLY

UBER

Leafly Holdings, Inc. (NASDAQ:LFLY) reported an 18% YoY drop in Q2 revenue to $8.7 million. Despite a decrease in retail accounts, average spending per account increased. The company also announced a partnership upgrade with Uber Eats (NYSE:UBER) for cannabis delivery in Alberta, Canada. Leafly's shares rose 4.85% to $2.16.

Portfolio Pulse from Nina Zdinjak

August 09, 2024 | 1:55 pm

REFI

SSIC

Silver Spike Investment Corp. (NASDAQ:SSIC) reported higher Q2 net income and declared a $0.25 dividend. The company saw total investment income of $3.1 million and net investment income of $1.5 million. Net asset value per share slightly decreased due to dividend payments. Silver Spike also announced a loan portfolio acquisition agreement with Chicago Atlantic Loan Portfolio (NASDAQ:REFI).

Portfolio Pulse from Nina Zdinjak

August 09, 2024 | 1:37 pm

JMIA

Jumia has filed a prospectus for the sale of 20.23 million ADSs through an ATM offering. Pernod Ricard has purchased 1.27 million ADSs as part of this offering, continuing its role as a shareholder and strategic partner since 2019.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 1:17 pm

SCLX

Scilex Holding Company (NASDAQ:SCLX) has entered a Master Distributor Agreement with Devart Middle East Food Supplements and CH Trading Group to distribute ZTlido in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa. This agreement aims to expand the commercialization of ZTlido and potentially other non-opioid pain management products in the Middle East and North/South Africa markets.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 1:08 pm

ALK

Alaska Airlines has renewed its partnership with Air Space Intelligence to enhance AI-driven flight operations. This move reinforces the airline's commitment to fuel efficiency and sustainability as part of its long-term goal to achieve net zero emissions.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 1:06 pm

KITT

Nauticus shares are trading higher after the company contracted with Florida Atlantic University to perform development testing of the Aquanaut Mark 2 vehicle in the protected waters near the university's Institute for Ocean and Systems Engineering Dania Beach facilities, as well as in the deeper waters of the Atlantic Ocean.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 1:05 pm

COIN

A virtual meeting between the cryptocurrency industry and Democratic Party officials, hosted by Congressman Ro Khanna, aimed to ease tensions but turned confrontational. Crypto executives criticized the Biden administration's regulatory actions, while Anthony Scaramucci expressed optimism about Kamala Harris's potential to gain support within the crypto community.

Portfolio Pulse from Murtuza Merchant

August 09, 2024 | 1:05 pm

MRIN

RDDT

Marin Software Incorporated (NASDAQ:MRIN) shares surged after the company enhanced its integrations with Reddit, Inc. (NYSE:RDDT) and X (formerly Twitter). The integration allows marketers to leverage Marin’s AI-driven tools to target users on these platforms. Marin's CEO highlighted the benefits of this integration for digital marketers. Despite recent financial losses, the stock saw a significant premarket increase.

Portfolio Pulse from Lekha Gupta

August 09, 2024 | 12:31 pm

DOCS

IOVA

KITT

Market-Moving News for August 9th includes significant updates for Nauticus Robotics (KITT), Iovance Biotherapeutics (IOVA), and Doximity (DOCS). Nauticus Robotics has partnered with Florida Atlantic University for cost-effective testing of Aquanaut Mark 2. Iovance Biotherapeutics reported better-than-expected Q2 financial results and issued Q3 product revenue guidance above estimates. Doximity also reported better-than-expected Q1 financial results and issued Q2 and FY24 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 12:16 pm